The group is working on understanding the mechanisms involved in renal physiopathology. One of its main lines of research is the role that androgens play. Another important part of the group’s efforts is the early detection of biomarkers for kidney dysfunction, with high performance proteomic analysis and blood and urine samples from patients transplanted under different immunosuppressant regimes. The relationship between the institute’s nephrologists, urologists and pathologists promotes collaboration with the aim of identifying potential biomarkers and therapeutic targets that may be useful in future clinical interventions.

In terms of paediatrics, the group is investigating hereditary kidney disease, haemolytic-uraemic syndrome, focal segmental glomerulosclerosis, paediatric dialysis, paediatric kidney transplantation, and chronic kidney disease in infants and adolescents. In adults, the group is working on cancer and kidney transplants.

It is also studying the possibility of using sensors to detect biomarkers and nanoconjugates for pharmacological release, opening up new perspectives for patient monitoring and targeted therapy.

Visit the research group’s page

Ponderació
9

Subscribe to our newsletters and be a part of Campus Life

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.